Rosenblatt analyst Blair Abernethy maintains Datadog (NASDAQ:DDOG) with a Buy and lowers the price target from $120 to $105.
GH Research Psychedelics Firm Q2 2023 Repots $238M Cash To Accelerate 5-MeO-DMT Programs Into 2026
GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharma company developing novel mebufotenin (5-MeO-DMT) therapies for Treatment-Resistant Depression (TRD) and one of the highest trading psychedelics stocks listed in Nasdaq, shared its financial results and business updates for its second quarter en
